Acousort AB
STO:ACOU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Acousort AB
Other Items
Acousort AB
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Acousort AB
STO:ACOU
|
Other Items
-kr488k
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Other Items
kr256k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Other Items
-kr685k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Other Items
-kr55m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-234%
|
CAGR 10-Years
-20%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Other Items
-kr1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Other Items
-kr894.7m
|
CAGR 3-Years
-3 647%
|
CAGR 5-Years
-606%
|
CAGR 10-Years
N/A
|
|
Acousort AB
Glance View
AcouSort AB engages in the provision of biotechnology. The company is headquartered in Lund, Skane. The company went IPO on 2017-01-09. The firm develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
See Also
What is Acousort AB's Other Items?
Other Items
-488k
SEK
Based on the financial report for Dec 31, 2025, Acousort AB's Other Items amounts to -488k SEK.
What is Acousort AB's Other Items growth rate?
Other Items CAGR 5Y
-2%
Over the last year, the Other Items growth was 52%. The average annual Other Items growth rates for Acousort AB have been 8% over the past three years , -2% over the past five years .
